On the other hand, patients with both vasculitis and AAT deficiency have been reported to have a reduced ability to bind PR3 released by neutrophils previously activated, thus promoting PR3-mediated proteolytic vessel damage. The gene discussed is PRTN3; the disease is alpha 1-antitrypsin deficiency.